Medications in the treatment of borderline personality disorder 2006
- PMID: 17257515
- DOI: 10.1007/s11920-007-0010-1
Medications in the treatment of borderline personality disorder 2006
Abstract
This review covers all significant randomized controlled trials and open trials of medications for the treatment of borderline personality disorder. New developments in the effectiveness of mood stabilizers and antipsychotics are discussed. Differences were found in the effectiveness of medications based on the presence or absence of depression and significant anger symptoms. Medications continue to be recommended as adjuncts to psychotherapy. Most of the trials discussed require replication, and more trials that investigate the effectiveness of medications in combination with psychotherapy are recommended.
Similar articles
-
Psychopharmacological treatment in borderline personality disorder.Actas Esp Psiquiatr. 2008 Jan-Feb;36(1):39-49. Actas Esp Psiquiatr. 2008. PMID: 18286399 Review.
-
[Update on Current Care Guideline: Borderline personality disorder].Duodecim. 2015;131(16):1484-5. Duodecim. 2015. PMID: 26485941 Review. Finnish.
-
Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.J Pers Disord. 2009 Apr;23(2):156-74. doi: 10.1521/pedi.2009.23.2.156. J Pers Disord. 2009. PMID: 19379093 Review.
-
Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?J Affect Disord. 2008 Nov;111(1):21-30. doi: 10.1016/j.jad.2008.01.024. Epub 2008 Mar 4. J Affect Disord. 2008. PMID: 18304647 Review.
-
Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.Am J Psychiatry. 2001 Oct;158(10 Suppl):1-52. Am J Psychiatry. 2001. PMID: 11665545 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical